Value sales of Rx/reimbursement adult incontinence grew by 5% in 2020, with the outbreak of COVID-19 creating some short-term disruptions to access, with some consumers facing difficulty accessing healthcare institutions. As a result, some members of the public struggled to obtain these products and instead, they were forced to rely on retail adult incontinence products.
Incontinence products are available on prescription in Slovakia for those who have severe incontinence problems which have been diagnosed by a doctor. Therefore, the majority of adult incontinence products sold in Slovakia fall under Rx/reimbursement adult incontinence.
Following the outbreak of COVID-19 in 2020, growth for Rx/reimbursement adult incontinence will remain positive over the forecast period, recording a CAGR of 3%. Due to an ageing population and improving awareness of incontinence, more and more people are expected to seek medical help over the coming years, supporting volume sales.
While the ageing population boosts growth, prevention from incontinence could start to impact sales over the forecast period. These include strategies such as regular exercise activities or treatments, including surgeries.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Slovakia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Slovakia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page